A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back.

An experimental vaccine targeting one of the most common genetic drivers of hard-to-treat pancreatic and colorectal cancers prevented their recurrence, raising hopes for an "off the shelf" treatment ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...

A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...

A groundbreaking pancreatic cancer vaccine shows promise in preventing recurrence, offering new hope for one of the deadliest cancers with historically low survival rates.

Black and Hispanic people are more likely to be diagnosed with pancreatic cancer and more likely to die from it. Now, one drug may help fix this.

Experimental vaccines shrouded in controversy and targeted by health secretary Robert F Kennedy Jr may protect against one of ...

The vaccine ELI-002 2P showed favorable relapse-free survival and overall survival in patients with pancreatic and colorectal ...